These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24521124)

  • 1. Absence of HIV-1 after treatment cessation in an infant.
    De Maria A
    N Engl J Med; 2014 Feb; 370(7):678. PubMed ID: 24521124
    [No Abstract]   [Full Text] [Related]  

  • 2. Absence of HIV-1 after treatment cessation in an infant.
    Persaud D; Luzuriaga K
    N Engl J Med; 2014 Feb; 370(7):678. PubMed ID: 24521123
    [No Abstract]   [Full Text] [Related]  

  • 3. Baby steps on the road to HIV eradication.
    Hammer SM
    N Engl J Med; 2013 Nov; 369(19):1855-7. PubMed ID: 24152231
    [No Abstract]   [Full Text] [Related]  

  • 4. Absence of detectable HIV-1 viremia after treatment cessation in an infant.
    Persaud D; Gay H; Ziemniak C; Chen YH; Piatak M; Chun TW; Strain M; Richman D; Luzuriaga K
    N Engl J Med; 2013 Nov; 369(19):1828-35. PubMed ID: 24152233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viremic relapse after HIV-1 remission in a perinatally infected child.
    Luzuriaga K; Gay H; Ziemniak C; Sanborn KB; Somasundaran M; Rainwater-Lovett K; Mellors JW; Rosenbloom D; Persaud D
    N Engl J Med; 2015 Feb; 372(8):786-8. PubMed ID: 25693029
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV-1 Very Low Level Viremia Is Associated with Virological Failure in Highly Active Antiretroviral Treatment-Treated Patients.
    Calcagno A; Motta I; Ghisetti V; Lo Re S; Allice T; Marinaro L; Milia MG; Tettoni MC; Trentini L; Orofino G; Salassa B; Di Perri G; Bonora S
    AIDS Res Hum Retroviruses; 2015 Oct; 31(10):999-1008. PubMed ID: 26165150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment.
    Baroncelli S; Pirillo MF; Tamburrini E; Guaraldi G; Pinnetti C; Degli Antoni A; Galluzzo CM; Stentarelli C; Amici R; Floridia M
    AIDS Res Hum Retroviruses; 2015 Jul; 31(7):673-8. PubMed ID: 25769019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-level viremia associated with the use of TaqMan assay.
    Szabo S; Moffett LE; Cantwell-McNelis K; James CW; Joseph A
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(4):203-5. PubMed ID: 20530465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial treatment of HIV-1 infection.
    Nicastri E; Narciso P; Andreoni M
    N Engl J Med; 2008 Aug; 359(9):970-1; author reply 971. PubMed ID: 18763319
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to Waters et al. "Successful use of genotypic resistance testing in HIV-1-infected individuals with detectable viraemia ...".
    Kan VL; Gale HB; Shinol RC
    AIDS; 2006 Oct; 20(15):1991-2. PubMed ID: 16988529
    [No Abstract]   [Full Text] [Related]  

  • 11. Measuring below the bar: what is it telling us?
    Daar ES
    AIDS; 2006 Nov; 20(18):2385-7. PubMed ID: 17117026
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid Initiation of Antiretrovirals in Two Newly Diagnosed HIV-infected Infants.
    Clarke DF; Yildirim I; Cooper ER
    Pediatr Infect Dis J; 2017 Jan; 36(1):61-62. PubMed ID: 27749654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-level viremia in HIV-1 infection: consequences and implications for switching to a new regimen.
    Cohen C
    HIV Clin Trials; 2009; 10(2):116-24. PubMed ID: 19487182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The independent effect of drug resistance on T cell activation in HIV infection.
    Hunt PW; Deeks SG; Bangsberg DR; Moss A; Sinclair E; Liegler T; Bates M; Tsao G; Lampiris H; Hoh R; Martin JN
    AIDS; 2006 Mar; 20(5):691-9. PubMed ID: 16514299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of antiretroviral therapy duration and intensification on isolated shedding of HIV-1 RNA in semen.
    Osborne BJ; Sheth PM; Yi TJ; Kovacs C; Benko E; Porte Cl; Huibner S; Le AQ; Danroth R; Baraki B; Mazzulli T; Brumme ZL; Kaul R
    J Infect Dis; 2013 Apr; 207(8):1226-34. PubMed ID: 23329849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undetectable Equals Untransmittable: A Game Changer for HIV Prevention.
    Patel RR; Curoe KA; Chan PA
    Clin Chem; 2020 Mar; 66(3):406-407. PubMed ID: 32109297
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term follow-up of patients taking tenofovir DF with low-level HIV-1 viremia and the K65R substitution in HIV-1 RT.
    Chappell BJ; Margot NA; Miller MD
    AIDS; 2007 Mar; 21(6):761-3. PubMed ID: 17413698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First International Workshop on HIV-1 Persistence During Therapy.
    Pomerantz R; Lafeuillade A;
    HIV Clin Trials; 2004; 5(1):40-9. PubMed ID: 15002086
    [No Abstract]   [Full Text] [Related]  

  • 19. Case records of the Massachusetts General Hospital. Case 18-2010. A 7-year-old boy with elevated HIV RNA levels despite antiretroviral medications.
    Meyers TM; Ndung'u T
    N Engl J Med; 2010 Jun; 362(24):2305-12. PubMed ID: 20554986
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary human immunodeficiency virus type 1 infection.
    Soogoor M; Daar ES
    Curr HIV/AIDS Rep; 2005 Jun; 2(2):55-60. PubMed ID: 16091249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.